Cannabis News Box

Cannabis Science will expand scope of sponsored research to include neurological conditions

Bethan Rose Jenkins, Cannabis News Writer/Editorial

March 11, 2019

Cannabis Science, Inc. (OTC: CBIS), a U.S.-based company that develops cannabinoid-based medicines,  has revealed its plans to broaden the extent of its sponsored medical cannabis research in Nigeria. Neurological conditions, such as Post-Traumatic Stress Disorder (PTSD), will be added to its re...

cbis research in nigeria